Kinetic and thermodynamics analysis: effect of eudragit polymer as drug release controller in electrospun nanofibers
Authors
Abstract:
The purpose of the present study was investigating kinetic and thermodynamic analysis using eudragit (EUD) polymer as controller to drug release mebendazole. nanofibers containing various proportions of EUD polymer, that were prepared with electrospinning technique. In this study, the amount of drug mebendazole release was investigated using nanofibers containing EUD at concentrations 50, 250, 500 ppm as controller at 0 -312 time by a Spectrophotometry (UV) method Measured. For every Nanofiber at 25 °C, 31 °C, 37 °C, and 43 °C, drug release studies were performed for 72 h. The nanofibers of EUD 500ppm, EUD 250 ppm and EUD 50ppm had the highest resistance to drug release, respectively. The results showed that EUD plays a very good role in controlling drug release at the nanofiber. Experimental data were done fitted better with the Sahlin-Peppas model. Kinetic studies have shown that due to the hydrophilic nature of EUD, both diffusion and swelling mechanisms contribute to the drug release process. Thermodynamic analysis showed that drug release leading to increased disorder (ΔS<0) is also an endothermic process (ΔH>0) and at all controlling concentrations is not spontaneous (ΔG>0). As the amount of the controller increases, activation energy increases.
similar resources
Application of guar gum in electrospun nanofibers as mebendazole drug release controller: a kinetic study and thermodynamics analysis
The current study aimed at in vitro investigating the kinetic study and thermodynamic analysis of mebendazole drug released from electrospun cellulose nanofiber in which guar gum is used as a release controller. The nanofibers were fabricated by electrospinning technique. The fibers were boosted by different controller guar gum 10 at 50, 250, and 500 ppm concentrations. The drug releas...
full textDrug release rate and kinetic investigation of composite polymeric nanofibers
Objective(s): In this work, electrospun nanofibers were explored as drug delivery vehicles using tetracycline as a model drug. Nanocomposite fibers including chitosan (CS)/poly (ethylene oxide) (PEO) and antibiotic were successfully prepared using electrospinning. CS blended with PEO considering a weight ratio of (90/10), and then, nanofibrous samples were successfully e...
full textdrug release rate and kinetic investigation of composite polymeric nanofibers
objective(s): in this work, electrospun nanofibers were explored as drug delivery vehicles using tetracycline as a model drug. nanocomposite fibers including chitosan (cs)/poly (ethylene oxide) (peo) and antibiotic were successfully prepared using electrospinning. cs blended with peo considering a weight ratio of (90/10), and then, nanofibrous samples were successfully electrospun from their a...
full textHemocompatibility assessment and drug release kinetics investigation from materials based on electrospun nanofibers
Objective(s): Polymeric nanofiber has a huge potential for a various biomedical applications such as wound healing and orthopedic implant. Since most of the future applications of therapeutic nanofiber are interacting with human blood components, it is important to investigate hemocompatibility. Methods: In this study, nanofibers with antibacterial properties were synthesizedby elec...
full textNanopottery: coiling of electrospun polymer nanofibers.
We show that a nanoscale polymer solution electrojet can coil to form free-standing hollow pottery as the jet is focused onto a sharp electrode tip. A scaling law is given based on the balance of the electrostatic compression force and the elastic resistance to predict the coil radius and frequency as the functions of relevant physical parameters. The structures formed by the nanofibers can be ...
full textMy Resources
Journal title
volume 8 issue 2
pages 171- 180
publication date 2020-04-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023